JP MORGAN/CALL/ABBOTT LABORATORIES/110/0.1/17.01.25 Stock

Warrant

DE000JL03GE6

Market Closed - Börse Stuttgart 02:58:19 2024-07-12 am EDT
0.46 EUR +9.52% Intraday chart for JP MORGAN/CALL/ABBOTT LABORATORIES/110/0.1/17.01.25
Current month-2.13%
1 month-17.86%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-12 0.46 +9.52%
24-07-11 0.42 +16.67%
24-07-10 0.36 -2.70%
24-07-09 0.37 -11.90%
24-07-08 0.42 +13.51%

Delayed Quote Börse Stuttgart

Last update July 12, 2024 at 02:58 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JL03GE
ISINDE000JL03GE6
Date issued 2023-04-05
Strike 110 $
Maturity 2025-01-17 (189 Days)
Parity 10 : 1
Emission price 1.06
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.71
Lowest since issue 0.33
Spread 0.02
Spread %4.35%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104.2 USD
Average target price
124.8 USD
Spread / Average Target
+19.72%
Consensus